Baxter International Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.13B | $10.56B | $10.16B | $9.97B | $10.72B | $9.41B | $13.94B | $13.89B |
| Renal | — | — | $3.86B | — | — | — | — | — |
| Hospital Products | — | — | $6.31B | — | — | — | — | — |
| Americas | $5.96B | $5.72B | — | — | — | — | — | — |
| EMEA | $2.96B | $2.73B | — | — | — | — | — | — |
| APAC | $2.21B | $2.11B | — | — | — | — | — | — |
| Hillrom | — | — | — | — | — | — | — | — |
| Medical Products and Therapies | — | — | — | — | — | — | — | — |
| Healthcare Systems and Technologies | — | — | — | — | — | — | — | — |
| Pharmaceuticals | — | — | — | — | — | — | — | — |
| Kidney Care | — | — | — | — | — | — | — | — |
| Other | — | — | — | — | — | — | — | — |
| Cost of Revenue | $6.34B | $6.11B | $6.05B | $5.82B | $6.14B | $5.25B | $6.80B | $6.85B |
| Gross Profit | $4.76B | $4.47B | $4.12B | $4.15B | $4.58B | $4.16B | $7.13B | $7.05B |
| Gross Margin | 42.8% | 42.4% | 40.5% | 41.6% | 42.7% | 44.2% | 51.2% | 50.7% |
| Operating Expenses | ||||||||
| Research & Development | $654.0M | $615.0M | $646.0M | $603.0M | $610.0M | $582.0M | $1.08B | $946.0M |
| SG&A Expense | $2.62B | $2.63B | $2.73B | $3.09B | $3.32B | $3.08B | $3.28B | $3.15B |
| Operating Income | $1.58B | $1.29B | $745.0M | $449.0M | $656.0M | $496.0M | $3.00B | $2.90B |
| Operating Margin | 14.2% | 12.2% | 7.3% | 4.5% | 6.1% | 5.3% | 21.5% | 20.9% |
| Interest Expense | $93.0M | $85.0M | $89.0M | $146.0M | $167.0M | $155.0M | $113.0M | $92.0M |
| Pretax Income | $1.62B | $1.10B | $4.95B | $428.0M | $490.0M | $375.0M | $2.89B | $2.81B |
| Income Tax Expense | $65.0M | $491.0M | $-12.0M | $35.0M | $33.0M | $60.0M | $555.0M | $553.0M |
| Net Income | $1.55B | $602.0M | $4.97B | $968.0M | $2.50B | $2.01B | $2.33B | $2.22B |
| Net Margin | 13.9% | 5.7% | 48.9% | 9.7% | 23.3% | 21.4% | 16.7% | 16.0% |
| EPS (Basic) | $2.90 | $1.11 | $9.09 | $1.78 | $4.61 | $3.70 | $4.22 | $3.91 |
| EPS (Diluted) | $2.83 | $1.08 | $9.01 | $1.76 | $4.56 | $3.66 | $4.18 | $3.88 |
| Shares Outstanding (Basic) | 534.0M | 543.0M | 546.0M | 545.0M | 542.0M | 543.0M | 551.0M | 569.0M |
| Shares Outstanding (Diluted) | 546.0M | 555.0M | 551.0M | 549.0M | 547.0M | 549.0M | 556.0M | 573.0M |
| Dividends Per Share | $0.73 | $0.61 | $0.51 | $1.27 | $2.05 | $1.92 | $1.57 | $1.27 |